Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Garg Pushkal Insider Profile
4 Followers
Garg Pushkal, Director at SQZ Biotechnologies, holds ― shares in SQZ Biotechnologies (Ticker: SQZB), holds 5.03K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Garg Pushkal ― shares of SQZ Biotechnologies on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+10.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Garg Pushkal holds in companies
Most Profitable Insider Trade
The most profitable trade made by Garg Pushkal
Garg Pushkal's Trading History
SQZ Biotechnologies
―
Director
―
―
Alnylam Pharma
Aug 07, 2023
CMO & EVP Dev & Med Affairs
Uninformative Buy
―
$890.91K
List of latest transactions for each holding click on a transaction to see Garg Pushkal's performance on stock
You May Also Like
Garg Pushkal insider profile FAQ
What is the percentage of profitable transactions made by Garg Pushkal?
The percentage of profitable transactions made by Garg Pushkal is 100%.
What is the average return per transaction made by Garg Pushkal?
The average return per transaction made by Garg Pushkal is 10.40%.
What stocks does Garg Pushkal hold?
Garg Pushkal holds: SQZB, ALNY stocks.
What was Garg Pushkal’s latest transaction?
Garg Pushkal latest transaction was an Uninformative Buy of ―.
What was Garg Pushkal's most profitable transaction?
Garg Pushkal’s most profitable transaction was an Informative Sell of ALNY stock on April 28, 2023. The return on the trade was 13.90%.
What is Garg Pushkal's role in SQZ Biotechnologies?
Garg Pushkal's role in SQZ Biotechnologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.